Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab And Argenx Announce Approval Of Efgartigimod Alfa Injection For Generalized Myasthenia Gravis In China

July 16 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB AND ARGENX ANNOUNCE APPROVAL OF EFGARTIGIMOD ALFA
INJECTION (SUBCUTANEOUS INJECTION) FOR GENERALIZED MYASTHENIA
GRAVIS IN CHINA

Source text for Eikon:  ID:nBw7myLrha 
Further company coverage:  9688.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zai Lab

See all news